On Demand Webinars
-
Can A Small Plasmid Produce Huge Benefits? The Power Of Small
1/17/2023
With benefits across applications, nanoplasmids are designed to replace antiquated bacterial backbones, while eliminating antibiotic markers that can cause regulatory concerns.
-
Democratizing RNA Nanotherapeutics
4/14/2022
This webinar is presented by Dr. John P. Cooke, Chair of the Department of Cardiovascular Sciences at the Houston Methodist Research Institute, Director of the Center for Cardiovascular Regeneration, and Medical Director of the RNA Therapeutics Program in the Houston Methodist DeBakey Heart and Vascular Center.
-
Analyzing COVID-19 Vaccine Purity Using LC-MS Technologies
11/8/2022
Explore why process-related impurities are a concern in vaccines and present results and learnings from LC-MS analyses of several mRNA- and protein-based vaccines for COVID-19.
-
Key Quality Attributes For mRNA Drug Substance Performance
5/23/2024
Explore the evolution of the mRNA-based therapeutics pipeline, and gain insights into the key quality attributes and associated analytics that influence mRNA performance, including best practices.
-
Overcome The Hidden Complexities Of mRNA Process Development
3/22/2023
Explore the challenges behind the perceived simplicity of mRNA process development, as well as characterization strategies and models for predicting process outcomes at early stages.
-
Discovery To Clinic: CRISPR-Based Therapies And Diagnostics
11/29/2023
As CRISPR use continues to grow, so has the demand for clinical-grade guide RNA. Learn about GMP sgRNA and their stringent process and manufacturing controls.
-
Purification Of DNA Oligonucleotides Using AEX Chromatography Webcast
4/25/2023
Explore impurities removed by strong anion exchange chromatography for the advancement of these molecules as therapeutics and a cost-effective, efficient, and scalable purification method.
-
Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders
Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.
-
DNA Vaccine Development In A Global Pandemic: A Personal Account
4/14/2022
Dr. Gerrit Borchard, University of Geneva, presents a personal account of DNA vaccine development in a global pandemic.
-
RNA Interference - From Single Gene Studies To Whole Genome Screens
11/7/2022
Endoribonuclease-prepared siRNAs (esiRNAs) are able to overcome the limitations of RNAi. Learn about esiRNAs, their advantages over standard siRNAs, and ways this technology is utilized in different research fields.